😴 Z-Drug vs Benzodiazepine Comparator Simulator

GABA-A Receptor Subunit Architecture

The pentameric receptor mixes alpha, beta, and gamma subunits.

• 5: Subunit count (pentameric assembly)
• 6: Alpha subtypes (alpha1–alpha6 variants)
• alpha/gamma: BZD site (interface pocket)
• alpha1beta2gamma2: Main subtype (most common CNS form)

Subunit composition placeholder

Short placeholder describing subunit arrangement and pocket location.

Zolpidem — Selective Alpha-1 Binding

Z-drugs target the alpha-1 pocket, sparing other subtypes.

• alpha-1: Primary target (sedative subunit)
• ~2.5 h: Half-life (short acting)
• minimal: Anxiolytic effect (low alpha-2/3 affinity)
• high: Selectivity ratio (vs benzodiazepines)

Selective binding placeholder

Short placeholder on narrow alpha-1 selective pharmacology.

Diazepam — Broad Subunit Binding

Benzodiazepines bind broadly across multiple alpha subtypes.

• alpha1,2,3,5: Targets (non-selective)
• 20–100 h: Half-life (long acting, active metabolites)
• strong: Anxiolytic effect (alpha-2/3 mediated)
• present: Memory effect (alpha-5 mediated)

Broad binding placeholder

Short placeholder on non-selective benzodiazepine pharmacology.

Tolerance Development Speed Comparison

Benzodiazepines build tolerance faster than Z-drugs.

• slower: Z-drug tolerance (placeholder rate)
• faster: BZD tolerance (placeholder rate)
• receptor downregulation: Mechanism (placeholder)
• 2–4 weeks: Onset window (placeholder estimate)

Tolerance curve placeholder

Short placeholder comparing tolerance slope between classes.

Dependence Risk Profile Comparison

Long-term benzodiazepine use carries higher dependence risk.

• lower: Z-drug risk (placeholder estimate)
• higher: BZD risk (placeholder estimate)
• BZD > Z-drug: Withdrawal severity (placeholder)
• 2–4 weeks: Guideline duration (placeholder max)

Dependence risk placeholder

Short placeholder on cumulative dependence risk profile.

Short placeholder callout on tapering and clinical caution.